Apple Stock Gets Price-Target Cut On Mounting Challenges

JPMorgan cut its price target on Apple stock to $230, citing an anticipated 9% decline in iPhone 17 build plans to 85 million units due to macroeconomic uncertainty and earlier demand pull-in, though it maintains an "overweight" rating and foresees a stronger iPhone 18 cycle driven by foldable technology and advanced AI features. Concurrently, Wall Street analysts are divided on Apple's rumored acquisition of AI startup Perplexity AI; UBS views it as a costly, defensive move with unclear benefits given the startup's issues, while Loop Capital sees it as a strategic gain for AI talent and feature enhancement, especially as competitors like Samsung advance with AI-integrated foldable devices.

Analysis

JPMorgan has tempered its short-term outlook on Apple (AAPL) by reducing its price target to $230 from $240, despite reaffirming its 'overweight' rating. The adjustment is primarily driven by expectations of a weaker iPhone 17 cycle, with projected build plans for 2025 at 85 million units, a 9% decline compared to the iPhone 16's 93 million units. This anticipated slowdown is attributed to macroeconomic uncertainty and a pull-forward of demand from consumers acting ahead of potential tariff hikes. However, the bank anticipates a stronger rebound with the iPhone 18 series, contingent on the successful launch of a foldable device and more substantive, long-awaited AI features. This product cycle uncertainty is compounded by a strategic debate over Apple's AI direction, specifically a rumored deal with Perplexity AI. Analysts are divided: UBS views a potential acquisition as a costly ($14 billion+) and defensive maneuver with unclear benefits and reputational risks, warranting a 'neutral' rating and a $210 price target. Conversely, Loop Capital sees it as a necessary strategic move to acquire AI talent and bolster Siri, though it maintains a 'hold' rating with a $215 target. The market appears to be pricing in this ambiguity, as reflected by the stock's middling IBD Composite Rating of 53 out of 99.

Key Decisions for Investors

• Investors should weigh the near-term risk of a weaker iPhone 17 demand cycle against the potential long-term catalyst of a significant product refresh with the iPhone 18, which is expected to feature a foldable design and advanced AI.
• Closely monitor news related to a potential acquisition of or partnership with Perplexity AI, as a deal could be interpreted by the market as either a defensive, high-risk move or a strategic accelerant for Apple's AI capabilities.
• Given the conflicting analyst price targets ranging from $210 to $230 and a subdued IBD Composite Rating of 53, a neutral or hold position may be prudent until a clearer catalyst emerges for either the product roadmap or the AI strategy.